Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity
- PMID: 2255914
- DOI: 10.1126/science.2255914
Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity
Abstract
A fusion complementary DNA in the T cell line HSB-2 elucidates a provocative mechanism for the disruption of the putative hematopoietic transcription factor SCL. The fusion cDNA results from an interstitial deletion between a previously unknown locus, SIL (SCL interrupting locus), and the 5' untranslated region of SCL. Similar to 1;14 translocations, this deletion disrupts the SCL 5' regulatory region. This event is probably mediated by V-(D)-J recombinase activity, although neither locus is an immunoglobulin or a T cell receptor. Two other T cell lines, CEM and RPMI 8402, have essentially identical deletions. Thus, in lymphocytes, growth-affecting genes other than immune receptors risk rearrangements.
Similar articles
-
Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.Leuk Res. 2003 Jul;27(7):575-82. doi: 10.1016/s0145-2126(02)00260-6. Leuk Res. 2003. PMID: 12681356
-
Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.J Biol Chem. 2001 Aug 3;276(31):29126-33. doi: 10.1074/jbc.M103797200. Epub 2001 Jun 4. J Biol Chem. 2001. PMID: 11390401
-
Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias.Genes Chromosomes Cancer. 1990 Jan;1(3):194-208. doi: 10.1002/gcc.2870010303. Genes Chromosomes Cancer. 1990. PMID: 1964581
-
RAG1 and RAG2 in V(D)J recombination and transposition.Immunol Res. 2001;23(1):23-39. doi: 10.1385/IR:23:1:23. Immunol Res. 2001. PMID: 11417858 Review.
-
Around the V(D)J recombinase machinery.Res Immunol. 1994 Feb;145(2):151-4; discussion 155-8. doi: 10.1016/s0923-2494(94)80030-8. Res Immunol. 1994. PMID: 8079049 Review. No abstract available.
Cited by
-
Oncogenic Enhancers in Leukemia.Blood Cancer Discov. 2024 Sep 3;5(5):303-317. doi: 10.1158/2643-3230.BCD-23-0211. Blood Cancer Discov. 2024. PMID: 39093124 Review.
-
Principles and therapeutic applications of adaptive immunity.Cell. 2024 Apr 25;187(9):2052-2078. doi: 10.1016/j.cell.2024.03.037. Cell. 2024. PMID: 38670065 Free PMC article. Review.
-
ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia.Haematologica. 2024 May 1;109(5):1325-1327. doi: 10.3324/haematol.2023.284447. Haematologica. 2024. PMID: 38105739 Free PMC article. No abstract available.
-
Neoplasia-associated Chromosome Translocations Resulting in Gene Truncation.Cancer Genomics Proteomics. 2022 Nov-Dec;19(6):647-672. doi: 10.21873/cgp.20349. Cancer Genomics Proteomics. 2022. PMID: 36316036 Free PMC article. Review.
-
E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia.Front Immunol. 2022 Apr 20;13:885144. doi: 10.3389/fimmu.2022.885144. eCollection 2022. Front Immunol. 2022. PMID: 35514954 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
